These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 22574174

  • 1. CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.
    Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G, REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.
    PLoS One; 2012; 7(5):e36512. PubMed ID: 22574174
    [Abstract] [Full Text] [Related]

  • 2. Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.
    Ma J, Guan M, Bowden DW, Ng MCY, Hicks PJ, Lea JP, Ma L, Gao C, Palmer ND, Freedman BI.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):1034-1043. PubMed ID: 27197912
    [Abstract] [Full Text] [Related]

  • 3. Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
    Albert C, Kube J, Albert A, Schanze D, Zenker M, Mertens PR.
    Nephron; 2019 Jun 06; 141(3):156-165. PubMed ID: 30557881
    [Abstract] [Full Text] [Related]

  • 4. UMOD as a susceptibility gene for end-stage renal disease.
    Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G, REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.
    BMC Med Genet; 2012 Sep 05; 13():78. PubMed ID: 22947327
    [Abstract] [Full Text] [Related]

  • 5. Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans.
    Uglebjerg N, Ahmadizar F, Aly DM, Cañadas-Garre M, Hill C, Naber A, Oddsson A, Singh SS, Smyth L, Trégouët DA, Chaker L, Ghanbari M, Steinthorsdottir V, Ahlqvist E, Hadjadj S, Van Hoek M, Kavousi M, McKnight AJ, Sijbrands EJ, Stefansson K, Simons M, Rossing P, Ahluwalia TS.
    Front Endocrinol (Lausanne); 2023 Sep 05; 14():1081741. PubMed ID: 36926036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L, members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU), Comité de Transplantation de l'Association Française d'Urologie (CTAFU).
    BJU Int; 2012 Dec 05; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis.
    Meier-Kriesche HU, Kaplan B.
    Transplantation; 2002 Nov 27; 74(10):1377-81. PubMed ID: 12451234
    [Abstract] [Full Text] [Related]

  • 12. The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys.
    Hayes JM, Steinmuller DR, Streem SB, Novick AC.
    Transplantation; 1991 Nov 27; 52(5):813-7. PubMed ID: 1949166
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC, Tam CH, Wang Y, Luk AO, Hu C, Yang X, Lam V, Chan AW, Ho JS, Chow CC, Tong PC, Jia W, Ng MC, So WY, Chan JC.
    JAMA; 2010 Aug 25; 304(8):881-9. PubMed ID: 20736472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal allograft survival in patients with oxalosis.
    Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU.
    Transplantation; 2002 Sep 15; 74(5):707-10. PubMed ID: 12352890
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
    Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, De Zeeuw D, De Jong PE.
    J Am Soc Nephrol; 1998 Nov 15; 9(11):2075-81. PubMed ID: 9808093
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of functional genetic variants of transcription factor Forkhead Box P3 and Nuclear Factor-κB with end-stage renal disease and renal allograft outcome.
    Misra MK, Mishra A, Pandey SK, Kapoor R, Sharma RK, Agrawal S.
    Gene; 2016 Apr 25; 581(1):57-65. PubMed ID: 26794449
    [Abstract] [Full Text] [Related]

  • 20. The fate of organs refused locally and transplanted elsewhere.
    Cadillo-Chávez R, Santiago-Delpín EA, González-Caraballo Z, Morales-Otero L, Saade M, Davis J, Heinrichs D.
    Transplant Proc; 2006 Apr 25; 38(3):892-4. PubMed ID: 16647501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.